Stocks · Health care · Pharmaceutical Preparations

CorMedix Inc.

CRMD Clue Score73
United States Fiscal year ends December CIK 0001410098 Results filed 2 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Joseph Todisco
16 Jan 2026
Chief Executive Officer
Exercised, kept
29,585
$3.38
$100.00K
Steven W Lefkowitz
12 Jan 2026
Director
Exercised, kept
15,000
$5.63
$84.45K
Gregory Scott Duncan
16 Sep 2025
Director
Exercised, kept
13,333
$8.32
$110.93K
Steven W Lefkowitz
2 Apr 2025
Director
Exercised, kept
20,000
$4.03
$80.60K
Joseph Todisco
1 Apr 2025
Chief Executive Officer
Exercised, kept
59,170
$3.38
$199.99K
Steven W Lefkowitz
16 Nov 2023
Director
Exercised, kept
15,000
$2.25
$33.75K
Steven W Lefkowitz
7 Jan 2020
Director
Exercised, kept indirect
3,000
$4.50
$13.50K
Steven W Lefkowitz
7 Jan 2020
Director
Exercised, kept
4,500
$4.50
$20.25K
Elizabeth Hurlburt
5 Dec 2018
EVP, Head of Clinical Ops.
Exercised, kept
40,000
$0.29
$11.60K
Gary A. Gelbfish
12 Oct 2018
Director
Exercised, kept
1,000,000
$1.05
$1.05M

What was left out

Form 4 filings counted 271
Amendments (4/A) skipped 20
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 13
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 5,135,252
Sales filed before the plan box existed 1
History held since 1 Apr 2010